s6y Raphael Pharmaceutical Inc. POS AM

Raphael Pharmaceutical Inc. POS AM, filed May 4, 2023: Consent of Weinstein International Cpa

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the use, in this Registration Statement on Form S-1, of our report dated March 23, 2023, relating to the financial statements of Raphael Pharmaceutical Inc. We also consent to the reference to us under the heading "Experts" in such Registration Statement. 

 

/s/ Weinstein International CPA

 

Weinstein International CPA

 

Tel Aviv, Israel

May 4, 2023